bolsia
Carteras
Blog
Forex
Clubs
Foro
Grupos
Login
Registrarse
FTSE
7,071
0.30%
EUROSTOXX50
3,222
-1.52%
DAX
11,619
0.56%
S&P 500
2,768
-0.04%
Acciones
Carteras
Top Carteras
Acciones
Fisgona
Bolsia Coins
Referrals
Ayuda
Comprar Acciones
Acciones US
Gráfico
Máximo Cartera del Juego:
25%
Company
Quote
Time
Merck & Co Inc (MRK)
$72.32
(-0.01%)
22:00
(19/10/2018)
Portfolios Holding
MRK
Burbujarra 216.9%
Burbujachoc2 79.0%
Aaron 70.7%
Alendrozar 26.7%
News
JPMorgan Chase Gives Overweight Rating to Merck & Co (MRK)
Biotech: Core and Explore - Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Healthcare Review: Eli Lilly & Co.(NYSE:LLY), Merck & Co., Inc.(NYSE:MRK)
MERCK & CO., INC. : Merck's Resubmitted Sugammadex Sodium Injection NDA ...
MERCK & CO., INC. : Merck Provides Update on Next Steps for TREDAPTIVE ...
MERCK & CO., INC. : Merck to Stop Selling Tredaptive After Drug Failed in Study
MERCK & CO., INC. : Merck to Suspend Availability of Tredaptive Worldwide ...
MERCK & CO., INC. : Merck steers doctors away from HDL cholesterol drug
MERCK & CO., INC. : Merck Announces FDA Acceptance of Resubmission of ...
Healthcare Review: Amgen, Inc.(NASDAQ:AMGN), Merck & Co., Inc.(NYSE:MRK)
Former Merck & Co. employee sues for discriminatory firing
Dr Reddy's Starts US Sales of Generic Drug to Treat Male Baldness
MERCK & CO., INC. : Merck Announces FDA Acknowledgement of ...
MERCK & CO., INC. : Merck to Present at the 31st Annual J.P. Morgan ...
Merck & Co Inc Announces FDA Acceptance Of New Drug Application For Suvorexant, Investigational Insomnia Medicine
Merck & Co Inc Announces Interim Results From Phase II, Multi-center, Randomized, Dose-ranging Study Assessing Safety And Antiviral Activity Of MK-5172
Merck Combination Cholesterol Drug Fails to Meet Study Goals; Firm Doesn't ...
MERCK & CO., INC. : Merck says cholesterol drug study failed
MERCK & CO., INC. : Merck Announces HPS2-THRIVE Study of TREDAPTIVE ...
European watchdog starts safety review of Merck cholesterol drug